• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4607200)   Today's Articles (1340)   Subscriber (49374)
For: Kelleher FC, Solomon B, McArthur GA. Molecular therapeutic advances in personalized therapy of melanoma and non-small cell lung cancer. J Pers Med 2012;2:35-49. [PMID: 25562798 DOI: 10.3390/jpm2020035] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2012] [Revised: 03/25/2012] [Accepted: 04/03/2012] [Indexed: 01/07/2023]  Open
Number Cited by Other Article(s)
1
Robles AI, Jen J, Harris CC. Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harb Perspect Med 2016;6:a026294. [PMID: 27449973 PMCID: PMC5008065 DOI: 10.1101/cshperspect.a026294] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
2
Xue F, Zhu L, Wang L, Wang Q. Serum neuron specific enolase levels correlate with patient prognosis for advanced lung cancer. Int J Clin Exp Med 2015;8:9498-9504. [PMID: 26309614 PMCID: PMC4538059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2015] [Accepted: 05/28/2015] [Indexed: 06/04/2023]
3
Li XN, Qiu D, Pan X, Hou XX. Mutation of the epidermal growth factor receptor gene and its impact on the efficacy of gefitinib in advanced non-small cell lung cance. Int J Clin Exp Med 2015;8:5397-5405. [PMID: 26131116 PMCID: PMC4483999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Accepted: 03/26/2015] [Indexed: 06/04/2023]
4
Thérapies ciblées et mélanome : aspects pratiques et implications pour la prise en charge. ONCOLOGIE 2013. [DOI: 10.1007/s10269-013-2252-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
5
Meyer UA, Zanger UM, Schwab M. Omics and drug response. Annu Rev Pharmacol Toxicol 2012;53:475-502. [PMID: 23140244 DOI: 10.1146/annurev-pharmtox-010510-100502] [Citation(s) in RCA: 112] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA